EP3397244
Title:
TREATMENT OF BREAST CANCER USING A COMBINATION OF A CATIONIC LIPOSOMAL FORMULATION OF TAXANE, A NON-LIPOSOMAL FORMULATION OF TAXANE AND A FURTHER ACTIVE AGENT
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP3397244
WO Application Number:
IB2016058055
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP16881378.0
WO Publication Number:
WO2017115301
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Taiwan, Chinese Taipei (TW)
Publications:
Dates
Filing date:
28/12/2016
Grant date:
06/10/2021
EP Publication Date:
07/11/2018
WO Publication Date:
06/07/2017
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
06/10/2021
EP B1 Publication Date:
06/10/2021
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
27/12/2036
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
06/10/2021
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
06/10/2021
Name:
Syncore Biotechnology Co., Ltd.
Address:
No. 84, Zhongshan Rd.
Dongshan Township, Yilan County 26944, Taiwan, Chinese Taipei (TW)
From:
06/10/2021
Name:
Cancap Pharmaceutical Ltd.
Address:
Unit 180, 13111 Vanier Place, Richmond, British Columbia, Canada (CA)